Incyte Corp. (INCY)
115.30
-1.84
(-1.57%)
USD |
NASDAQ |
Oct 02, 16:00
115.30
0.00 (0.00%)
After-Hours: 20:00
Incyte Market Cap : 23.17B for Oct. 2, 2026
Market Cap Chart
Historical Market Cap Data
| Date | Value |
|---|---|
| October 02, 2026 | 23.17B |
| October 01, 2026 | 23.54B |
| September 30, 2026 | 24.39B |
| September 29, 2026 | 24.76B |
| September 28, 2026 | 25.09B |
| September 25, 2026 | 24.90B |
| September 24, 2026 | 25.01B |
| September 23, 2026 | 25.05B |
| September 22, 2026 | 25.51B |
| September 21, 2026 | 25.05B |
| September 18, 2026 | 25.18B |
| September 17, 2026 | 25.65B |
| September 16, 2026 | 25.07B |
| September 15, 2026 | 24.47B |
| September 14, 2026 | 24.56B |
| September 11, 2026 | 24.41B |
| September 10, 2026 | 24.78B |
| September 09, 2026 | 25.33B |
| September 08, 2026 | 25.00B |
| September 04, 2026 | 25.47B |
| September 03, 2026 | 25.73B |
| September 02, 2026 | 25.89B |
| September 01, 2026 | 25.12B |
| August 31, 2026 | 24.76B |
| August 28, 2026 | 25.00B |
| Date | Value |
|---|---|
| August 27, 2026 | 25.67B |
| August 26, 2026 | 25.75B |
| August 25, 2026 | 26.07B |
| August 24, 2026 | 25.72B |
| August 21, 2026 | 25.69B |
| August 20, 2026 | 25.57B |
| August 19, 2026 | 25.82B |
| August 18, 2026 | 24.81B |
| August 17, 2026 | 24.82B |
| August 14, 2026 | 24.15B |
| August 13, 2026 | 24.22B |
| August 12, 2026 | 24.27B |
| August 11, 2026 | 24.33B |
| August 10, 2026 | 24.43B |
| August 07, 2026 | 24.23B |
| August 06, 2026 | 23.79B |
| August 05, 2026 | 24.08B |
| August 04, 2026 | 24.24B |
| August 03, 2026 | 23.80B |
| July 31, 2026 | 24.02B |
| July 30, 2026 | 24.72B |
| July 29, 2026 | 25.54B |
| July 28, 2026 | 26.11B |
| July 27, 2026 | 23.89B |
| July 24, 2026 | 23.65B |
Market Capitalization Definition
Market Capitalization measures the total value of a company based on their stock price multiplied by the shares outstanding. This metric is important because it gives you an idea of the size of a company, and how the size has changed over time. When studying companies from a relative basis, it would make sense to compare companies that have a similar market capitalization because factors like market share, economies of scale, and business models would also be similar.
Market Cap Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
Market Cap Benchmarks
| Regeneron Pharmaceuticals, Inc. | 76.02B |
| Mirum Pharmaceuticals, Inc. | 5.370B |
| Vertex Pharmaceuticals, Inc. | 127.87B |
| Alnylam Pharmaceuticals, Inc. | 29.38B |
| AbbVie, Inc. | 464.42B |
Market Cap Related Metrics
| PE Ratio | 14.69 |
| PS Ratio | 4.068 |
| PEG Ratio | 0.1875 |
| Price to Book Value | 3.652 |
| Price to Free Cash Flow | 12.52 |
| Price | 115.30 |
| Earnings Yield | 6.81% |
| PEGY Ratio | 0.1875 |
| Operating PE Ratio | 12.87 |
| Normalized PE Ratio | 14.47 |